Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination. - Wikidata - awgldk - TriplyDB

Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.

Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.

http://www.wikidata.org/entity/Q35886450

about

CpG Oligonucleotides as Cancer Vaccine Adjuvants Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma.Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives.Oncolytic viruses-immunotherapeutics on the rise.Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model.Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy.Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination.Current challenges for cancer vaccine adjuvant development.Genetic screen in myeloid cells identifies TNF-α autocrine secretion as a factor increasing MDSC suppressive activity via Nos2 up-regulation

P2860

Q26783826-796AF610-F97D-4C24-85A2-1244FA97B6CE Q28067023-4ADE2062-9DF7-4E25-A8D4-0E4C167476B0 Q28076161-14260706-9137-46EB-8FAF-1FC7CE63DE40 Q37014134-6099A832-894F-458E-B8FD-C2480FAD79D2 Q38853680-1C998B3D-4B03-4A85-941E-B185B50EC459 Q38919107-D61E6353-98C8-4C8C-BEF8-0A6DC42F96A4 Q39382025-87941053-2E1B-4122-B647-EF9643814634 Q39387174-D8F1680D-4C17-435C-96CD-3B84C7E690FE Q47358830-15787F94-F1AA-46A1-B95C-C7C06CE2C3F1 Q48160317-B3CB8E3E-3A51-428A-846D-B64C11EEF181 Q58759808-C52B46E2-83C1-40E9-B22A-58640B9AD013

P2860

Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.

http://www.wikidata.org/entity/Q35886450

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Adjuvants and myeloid-derived ...... herapeutic cancer vaccination.

@ast

Adjuvants and myeloid-derived ...... herapeutic cancer vaccination.

@en

type

label

Adjuvants and myeloid-derived ...... herapeutic cancer vaccination.

@ast

Adjuvants and myeloid-derived ...... herapeutic cancer vaccination.

@en

prefLabel

Adjuvants and myeloid-derived ...... herapeutic cancer vaccination.

@ast

Adjuvants and myeloid-derived ...... herapeutic cancer vaccination.

@en

P1433

Q35886450-18FABCAC-8C49-49B6-9EE5-3E199688E26E

P1476

Q35886450-A410F8B1-61E0-4FC5-8AAE-D36B80B551F5

P2093

Q35886450-5353E027-71A3-4435-87A0-46EFED9EFA60

Q35886450-7B5E3283-DD3C-43DA-932A-C9BF57FF5CA2

Q35886450-945D4772-0C1A-4587-AD2C-F707D8DE650B

Q35886450-97A3AB25-C915-4C65-A6D4-888B24C8EEBA

Q35886450-E1CE1A86-0BE0-4302-916D-10ABAEF06476

Q35886450-FBB4BC30-8014-4162-9478-8EC47FCAD313

P2860

Q35886450-0970F87E-5ACF-4C4D-87EF-1BF93F70422B

Q35886450-0A089958-46B0-449F-9077-6C4085D316F8

Q35886450-0A08C426-52DE-43AC-A711-8EC2191927F7

Q35886450-0B666CAA-AF08-40A5-891E-D807F88685C5

Q35886450-0D245AC2-F4ED-4911-8955-C3DA8D9702B1

Q35886450-0DE1D4CE-2E0D-4427-B385-54520B279702

Q35886450-130751DB-B812-40EC-9143-85EEA40FBB73

Q35886450-154DBE85-CE14-423B-A6E7-4568EA06DAF8

Q35886450-161D319B-21BE-403A-9BB1-E10959B89E13

Q35886450-1626A802-ACBD-430A-A785-573AFA33DCCD

P304

Q35886450-F22F8CEC-3FFC-434A-AD5D-62A37C8F07F4

P31

Q35886450-5DF78471-C2DF-47A0-9A6A-E65B08B7A877

P356

Q35886450-84566F85-A03F-42E3-92DF-90E9A993EA00

P433

Q35886450-DE343F99-6170-4691-AB0B-A30E9C0C977D

P478

Q35886450-8A1AF5A8-397F-4776-8823-5FA4A6332C92

P577

Q35886450-FD8E73A6-338C-4044-85E2-56AD0B932131

P5875

Q35886450-4662BFE6-A3C1-43B6-AD8C-2697D945F7D1

P698

Q35886450-3E59A5EA-D31A-4134-8CDD-FBD56A07C267

P932

Q35886450-59ABE10A-BF44-43DA-8E7C-2E559DE21B0F

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Adjuvants and myeloid-derived ...... herapeutic cancer vaccination.

@en

P2093

Audry Fernández

http://www.w3.org/2001/XMLSchema#string

Circe Mesa

http://www.w3.org/2001/XMLSchema#string

Kelvin P Lee

http://www.w3.org/2001/XMLSchema#string

Liliana Oliver

http://www.w3.org/2001/XMLSchema#string

Luis E Fernández

http://www.w3.org/2001/XMLSchema#string

Rydell Alvarez

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunotherapy: moving beyond current vaccines

Regulation of immunotherapeutic products for cancer and FDA's role in product development and clinical evaluation

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Myeloid-derived suppressor cells as regulators of the immune system

Coordinated regulation of myeloid cells by tumours

Interleukin 12 a key immunoregulatory cytokine in infection applications

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

Proteolysis and antigen presentation by MHC class II molecules

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

P304

3251-3260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.29847

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269280889

http://www.w3.org/2001/XMLSchema#string

P698

25483674

http://www.w3.org/2001/XMLSchema#string

P932

4514045

http://www.w3.org/2001/XMLSchema#string